Dr Reddy's launches generic anti-depressant drug in US

Dr Reddy's Laboratories today said it has launched Bupropion extended release tablets, an anti-depressant, in the US market.
The company has launched the drug in strengths of 100 mg, 150 mg and 200 mg, Dr Reddy's Laboratories said in a regulatory filing.
The company's product is generic version of GSK's Wellbutrin SR.
According to IMS Health, Wellbutrin SR brand and generics had US sales of around USD 109.6 million for 12 months ended July 2016.
Dr Reddy's Buproprion SR tablets are available in 100 mg, 150 mg and 200 mg in bottle count sizes of 60, 100 and 500, it said.

Wellbutrin SR is a registered tardemark of GSK group of companies.